Levetiracetam 1 A Pharma 250 mg, filmomhulde tabletten

Levetiracetam 1 A Pharma are an antiepileptic medicine (a medicine used to treat seizures in epilepsy).

This medicine is used:

• on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy, to treat partial onset seizures with or without secondary generalisation
• as an add-on to other antiepileptic medicines to treat : o partial onset seizures with or without generalisation in adults, adolescents, children and infants from 1 month age. o myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. o primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Do NOT take Levetiracetam 1 A Pharma:

• if you are allergic (hypersensitive) to levetiracetam or any of the other ingredients of Levetiracetam 1 A Pharmathis medicine (listed in Section 6).

Warnings and precautions

Talk to your doctor before taking Levetiracetam 1 A Pharma if you:

• have kidney problems, follow your doctor’s instructions, your dose may need to be adjusted.
• notice any slow down in the growth or unexpected puberty development of your child, please contact your doctor.
• notice an increase in seizure severity (e.g. increased number), please contact your doctor.
• have any symptoms of depression and / or suicidal ideation, please contact your doctor. A small number of people being treated with antiepileptics such as Levetiracetam 1 A Pharma have had thoughts of harming or killing themselves.

Other medicines and Levetiracetam 1 A Pharma

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Levetiracetam 1 A Pharma with food, drink and alcohol

You can take Levetiracetam 1 A Pharma with or without food. As a safety precaution, do not take Levetiracetam 1 A Pharma with alcohol.

Pregnancy and breast-feeding

Ask your doctor or pharmacist for advice before taking any medicine.

If you are pregnant or if you think you may be pregnant, please inform your doctor. Levetiracetam 1 A Pharma should not be used during pregnancy unless clearly necessary. The potential risk to your unborn child is unknown. This medicine has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures.

Breast-feeding is not recommended during treatment.

Driving and using machines

Levetiracetam 1 A Pharma may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy. This is more likely at the beginning of treatment or after an increase in the dose. You should not drive or use machines until it is established that your ability to perform such activities is not affected.

Always take Levetiracetam 1 A Pharmathis medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Levetiracetam 1 A Pharma must be taken twice a day, once in the morning and once in the evening, at about the same time each day.

Take the number of tablets following your doctor’s instructions.

Monotherapy

Dose in adults and adolescents (from 16 years of age):

General dose: between 1000 mg (<For 250mg> 4 tablets <For 500mg> 2 tablets) and 3,000 mg (<For 250mg> 12 tablets <For 500mg> 6 tablets) each day.

When you will first start taking Levetiracetam 1 A Pharma, your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose.

<For 250mg>

Example: if your daily dose is 1,000 mg, you must take 2 tablets in the morning and 2 tablets in the evening.

<For 500mg>

Example: if your daily dose is 2,000 mg, you must take 2 tablets in the morning and 2 tablets in the evening.

<For 750mg>

Example: if your daily dose is 3,000 mg, you must take 2 tablets in the morning and 2 tablets in the evening.

<For 1000mg>

Example: if your daily dose is 2,000 mg, you must take 1 tablet in the morning and 1 tablet in the evening.

Add-on therapy

Dose in adults and adolescents (12 to 17 years) weighing 50 kg or more:

General dose: between 1,000 mg (<For 250mg> 4 tablets <For 500mg> 2 tablets) and 3,000 mg (<For 250mg> 12 tablets <For 500mg> 6 tablets) each day.

<For 250mg>

Example: if your daily dose is 1,000 mg, you must take 2 tablets in the morning and 2 tablets in the evening.

<For 500mg>

Example: if your daily dose is 1,000 mg, you must take 1 tablet in the morning and 1 tablet in the evening.

<For 750mg>

Example: if your daily dose is 1,500 mg, you must take 1 tablet in the morning and 1 tablet in the evening.

<For 1000mg>

Example: if your daily dose is 2,000 mg, you must take 1 tablet in the morning and 1 tablet in the evening.

Dose in infants (6 to 23 months), children (2 to 11 years) and adolescents (12 to 17 years) weighing less than 50 kg:

Your doctor will prescribe the most appropriate pharmaceutical form of levetiracetam according to the age, weight and dose.

Levetiracetam 100 mg/ml oral solution is a presentation more appropriate to infants and children under the age of 6 years.

General dose: between 20 mg per kg bodyweight and 60 mg per kg bodyweight each day.

<For 250mg>

Example: a general dose of 20 mg per kg bodyweight each day, you must give your 25 kg child 1 tablet in the morning and 1 tablet in the evening.

Dose in infants (1 month to less than 6 months):

Levetiracetam 1 A Pharma 100 mg/ml oral solution is a presentation more appropriate to infants.

Method of administration:

Swallow Levetiracetam 1 A Pharma tablets with a sufficient quantity of liquid (e.g. a glass of water).

Duration of treatment:

• Levetiracetam 1 A Pharma is used as a chronic treatment. You should continue the treatment for as long as your doctor has told you.
• DO NOT stop your treatment without your doctor’s advice as this could increase your seizures. If your doctor decides to stop your treatment, he/she will instruct you to gradually withdraw the treatment.

If you take more Levetiracetam 1 A Pharma than you should

The possible side effects of an overdose of Levetiracetam 1 A Pharma are sleepiness, agitation, aggression, decrease of alertness, inhibition of breathing and coma.

Contact your doctor if you took more tablets than you should. Your doctor will establish the best possible treatment of overdose.

If you forget to take Levetiracetam 1 A Pharma

Contact your doctor if you have missed one or more doses.

Do not take a double dose to make up for a forgotten tablet.

If you stop taking Levetiracetam 1 A Pharma

If you are stopping treatment, as with other antiepileptic medicines, Levetiracetam 1 A Pharma should be discontinued gradually to avoid an increase in seizures.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Like all medicines, Levetiracetam 1 A Pharmathis medicine can cause side effects, although not everybody gets them.

Some side effects such as sleepiness, tiredness and dizziness may be more common at the beginning of the treatment or at dose increase. These effects should however decrease over time.

Very common: may affect more than 1 user in 10

• nasopharyngitis;
• somnolence (sleepiness), headache.

Common: may affect 1 to 10 users in 100

• anorexia (loss of appetite);
• depression, hostility or aggression, anxiety, insomnia, nervousness or irritability;
• convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness), lethargy, tremor (involuntary trembling);
• vertigo (sensation of rotation);
• cough;
• abdominal pain, diarrhoea, dyspepsia (indigestion), vomiting, nausea;
• rash;
• asthenia/fatigue (tiredness).

Uncommon: may affect 1 to 10 users in 1000

• decreased number of blood platelets, decreased number of white blood cells;
• weight decrease, weight increase;
• suicide attempt and suicidal ideation, mental disorder, abnormal behaviour, hallucination, anger, confusion, panic attack, emotional instability/mood swings, agitation;
• amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration);
• diplopia (double vision), vision blurred;
• liver function test abnormal;
• hair loss, eczema, pruritus;
• muscle weakness, myalgia (muscle pain);
• injury.

Rare: may affect 1 to 10 users in 10,000

• infection;
• decreased number of all blood cell types;
• suicide, personality disorders (behavioural problems), thinking abnormal (slow thinking, unable to concentrate);
• uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity);
• pancreatitis;
• hepatic failure, hepatitis;
• skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes

and genitals (Stevens– Johnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis).

If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet.

5. How to store Levetiracetam 1 A Pharma

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the carton box and blister after EXP:. The expiry date refers to the last day of the month. The shelf life after first opening of the bottle is 100 days.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Store in the original package in order to protect from moisture.

What Levetiracetam 1 A Pharma contains

The active substance is called levetiracetam.

The other ingredients are:

Tablet core: povidone K25, cellulose microcrystalline, croscarmellose sodium, crospovidone (type A), silica colloidal anhydrous, talc, magnesium stearate.

<For 250mg>

Film-coating: hypromellose, hydroxypropylcellulose, macrogol type 6000, titanium dioxide (E171), talc, indigo carmine (E132).

<For 500mg>

Film-coating: hypromellose, hydroxypropylcellulose, macrogol type 6000, titanium dioxide (E171), talc, iron oxide yellow (E 172).

<For 750mg>

Film-coating: hypromellose, hydroxypropylcellulose, macrogol type 6000, titanium dioxide (E171), talc, iron oxide Red (E 172), iron oxide yellow (E 172).

<For 1000mg>

Film-coating: hypromellose, hydroxypropylcellulose, macrogol type 6000, titanium dioxide (E171), talc.

Levetiracetam 1 A Pharma is packaged in OPA/Al/PVC - Al blisters placed into cardboard boxes containing 10, 20, 30, 50, 60, 100 and 200 film-coated tablets.

Not all pack sizes may be marketed.

Levetiracetam 1 A Pharma 250 mg film-coated tablets:

Each film-coated tablet contains 250 mg levetiracetam.

Levetiracetam 1 A Pharma 500 mg film-coated tablets:

Each film-coated tablet contains 500 mg levetiracetam.

Levetiracetam 1 A Pharma 750 mg film-coated tablets:

Each film-coated tablet contains 750 mg levetiracetam.

Levetiracetam 1 A Pharma 1000 mg film-coated tablets:

Each film-coated tablet contains 1000 mg levetiracetam.

What Levetiracetam 1 A Pharma looks like and contents of the pack

Levetiracetam 1 A Pharma 250 mg film-coated tablets:

Light blue, oval, biconvex film-coated tablets, scored on both sides, debossed with LVT / 250 on one side.

The tablet can be divided into equal halves.

Levetiracetam 1 A Pharma 500 mg film-coated tablets:

Yellow, oval, biconvex film-coated tablets, scored on both sides, debossed with LVT / 500 on one side.

The tablet can be divided into equal halves.

Levetiracetam 1 A Pharma 750 mg film-coated tablets:

Apricot color, oval, biconvex film-coated tablets, scored on both sides, debossed with LVT / 750 on one side.

The tablet can be divided into equal halves.

Levetiracetam 1 A Pharma 1000 mg film-coated tablets:

White, oval, biconvex film-coated tablets, scored on both sides, debossed with LVT / 1000 on one side.

The tablet can be divided into equal halves.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

1 A Pharma GmbH

Keltenring 1 + 3

82041 Oberhaching

Duitsland

Manufacturer

Lek Pharmaceuticals d.d. Verovškova 57

1526 Ljubljana Slovenië

LEK S.A.

ul. Domaniewska 50 C 02-672 Warschau Polen

Salutas Pharma GmbH

Otto-von-Guericke Allee 1

39179 Barleben

Duitsland

S.C. Sandoz, S.R.L.

Str. Livezeni nr. 7A

RO-540472 Targu-Mures

Roemenië

MA-numbers:

RVG 108540

RVG 108541

RVG 108542

RVG 108543

This medicinal product is authorised in the Member States of the EEA under the following names:

RMS	Levetiracetam 1 A Pharma 250 mg, filmomhulde tabletten
NL	Levetiracetam 1 A Pharma 500 mg, filmomhulde tabletten
	Levetiracetam 1 A Pharma 750 mg, filmomhulde tabletten
	Levetiracetam 1 A Pharma 1000 mg, filmomhulde tabletten
AT	Levetiracetam 1A	Pharma 250 mg – Filmtabletten
	Levetiracetam 1A	Pharma 500 mg – Filmtabletten
	Levetiracetam 1A	Pharma 1000 mg – Filmtabletten
DE	Levetiracetam 1	A PHARMA 250mg Filmtabletten
	Levetiracetam 1	A PHARMA 500mg Filmtabletten
	Levetiracetam 1	A PHARMA 750mg Filmtabletten
	Levetiracetam 1	A PHARMA 1000mg Filmtabletten

This leaflet was last approved in November 2012.